References
- Pettit G. R., Kamano Y., Herald C. L., Tuinman A. A., Boettner F. E., Kizu H., Schmidt J. M., Baczynskyj L., Tomer K. B., Bontems R. J. The isolation and structure of a remarkable marine animal antineoplastic constituent: dolastatin 10. J. Am. Chem. Soc 1987; 109: 6883–6885
- Pettit G. R., Kamano Y., Dufresne C., Cerny R. L., Herald C. L., Schmidt J. M. Isolation and structure of the cytostatic linear depsipeptide dolastatin 15. J. Org. Chem 1989; 54: 6005–6006
- Bai R., Pettit G. R., Hamel E. Binding of dolastatin 10 to tubulin at a distinct site for peptide antimitotic agents near the exchangeable nucleotide and vinca alcaloid sites. J. Biol. Chem 1990; 265: 17141–17149
- Flandrin G., Daniel M. T. Cytochemistry in the classification of leukaemias. The leukaemic cell, D. Catovsky. Churchill-Livingstone, Edinburgh 1981; 43, 29
- Monner D. A. An assay for growth of mouse bone marrow cells in microtiter liquid culture using the tetrazolium salt MTT, and its application to studies of myelopoiesis. Immunol. Lett 1988; 19: 261–268
- Bai R., Pettit G. R., Hamel E. Dolastatin 10, a powerful cytostatic peptide derived from a marine animal. Inhibition of tubulin polymerization mediated through the vinca alkaloid binding domain. Biochem. Pharmacol 1990; 39: 1941–1949
- Rovera G., O'Brien T.G., Diamond L. Induction of differentiation of human promyclocytic leukemia cells by tumor promotors. Science 1979; 204: 868–870
- Kraft A. S., William F., Pettit G. R., Lilly M. B. Varied differentiation responses of human leukemias to bryostatin. J. Cancer Res 1989; 49: 1287–1293
- Stone R. M., Sariban E., Pettit G. R., Kufe D. W. Bryostatin 1 activates protein kinase C and induces monocytic differentiation of HL-60 cells. Blood 1988; 72: 208–213